Measuring Tumour Hypoxia with Pimonidazole and Comet Assay
Author Information
Author(s): Olive P L, Durand R E, Raleigh J A, Luo C, Aquino-Parsons C
Primary Institution: B.C. Cancer Research Centre/B.C. Cancer Agency
Hypothesis
Can pimonidazole binding effectively quantify hypoxic cells in tumours compared to the comet assay?
Conclusion
The flow cytometry analysis of pimonidazole binding provides an accurate estimate of radiobiological hypoxia in tumours.
Supporting Evidence
- Cells defined as anoxic bound 10.8 times more antibody than aerobic cells.
- Hypoxic fractions as low as 0.5% could be detected.
- The pimonidazole binding method agreed well with the comet assay results.
Takeaway
This study shows a new way to measure low oxygen levels in tumors using a special dye and a flow cytometer, which is like a super smart counting machine.
Methodology
Flow cytometry was used to analyze pimonidazole binding in SCCVII tumours, and results were compared to the comet assay.
Limitations
The study primarily focused on specific tumour types and may not generalize to all cancers.
Participant Demographics
Preliminary analyses included biopsies from 3 patients.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website